Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of articaine with epinephrine on blood glucose in diabetic vs non-diabetic patients
IRCT20230225057537N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of articaine in type 2 diabetes mellitus (T2DM), diabetes mellitus type 1 (T1D) and Post-dental procedure pain (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Change in blood glucose levels. Started Jun 2023; status: completed.
02
Drugs
articaine
03
Conditions
type 2 diabetes mellitus (T2DM)diabetes mellitus type 1 (T1D)Post-dental procedure pain
Beyond the preview
Go deeper on IRCT20230225057537N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230225057537N1.